Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma

Cancer

Volumn 86, Issue 8, 1999, Pages 1537-1543

  Sheu, Bor Ching ^a   Hsu, Su Ming ^a   Ho, Hong Nerng ^a   Lin, Rong Hwa ^a   Torng, Pao Ling ^a   Huang, Su Cheng ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

CD4 CD8 ratio; Cervical carcinoma; Lymph node metastasis; Tumor infiltrating lymphocytes

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHOCYTE COUNT; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ANTIGENS, CD4; ANTIGENS, CD8; CARCINOMA, SQUAMOUS CELL; CD4-CD8 RATIO; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; LYMPHOCYTES, TUMOR-INFILTRATING; NEOPLASM STAGING; UTERINE CERVICAL NEOPLASMS;

EID: 0033569833     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1537::AID-CNCR21>3.0.CO;2-D     Document Type: Article

References (28)

1. Casterllo G, Esposito G, Stellato G, Mora LD, Abate G, Germano A. Immunological abnormalities in patients with cervical carcinoma. Gynecol Oncol 1986;25:61-4.
2. Pillai MR, Balaram P, Padmanabhan TK, Nair MK. Monoclonal antibody defined phenotypes of peripheral blood lymphocytes in cancer of the uterine cervix. Am J Reprod Immunol 1987;14:141-3.
3. Mckenzie J, King A, Hare J, Fulford T, Wilson B, Stanley M. Immunocytochemical characterization of large granular lymphocytes in normal cervix and HPV associated disease. J Pathol 1991;165:75-80.
4. Ferguson A, Moore M, Fox H. Expression of MHC products and leucocyte differentiation antigens in gynaecological neoplasm: an immunohistological analysis of the tumour cells and infiltrating leucocytes. Br J Obstet Gynaecol 1985; 52:551-63.
5. + T lymphocytes are recruited to neoplastic cervix. J Clin Immunol 1995;15:130-6.
6. Ellenhorn JDI, Schreiber H, Bluestone JA. Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated mice. J Immunol 1990;144:2840-6.
7. Cayeux S, Richter G, Becker C, Beck C, Aicher A, Pezzutto A, et al. Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation. J Immunol 1997;158:2834-42.
8. Qin Z, Richter G, Schüler T, Ibe S, Cao X, Blankenstein T. B cells inhibit induction of T cell-dependent tumor immunity. Nature Med 1998;4:627-30.
9. Ebert EC, Roberts AI, Devereux D, Nagase H. Selective immunosuppressive action of a factor produced by colon cancer cells. Cancer Res 1990;50:6158-61.
10. O'Mahony AM, O'Sullivan GC, O'Connell J, Cotter TG, Collins JK. An immune suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage. J Immunol 1993; 151:4847-56.
11. Sulitzeanu D. Immunosuppressive factors in human cancer. Adv Cancer Res 1993;60:247-67.
12. O'Sullivan GC, Corbett AR, Shanahan F, Collins JK. Regional immunosuppression in esophageal squamous cancer. J Immunol 1996;157:4717-20.
13. Dietl JA, Horny HP, Buchholz F. Lymphoreticular cells in invasive carcinoma of the uterine cervix: an immunohistological study. Int J Gynaecol Obstet 1991;34:179-82.
14. Hilders CGJM, Houbier JGA, van Ravenswaay C, Velhuizen HH, Fleuren GJ. The association between HLA-expression and infiltration of immune cells in cervical carcinoma. Lab Invest 1993;69:651-9.
15. Hilders CGJM, Houbier JGA, Krul EJT, Fleuren GJ. The expression of histocompatibility leukocyte antigens in the pathway to cervical carcinoma. Am J Clin Pathol 1994;101:5-12.
16. Miescher S, Whiteside TL, Carrel S, von Fliedner V. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumor: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 1986;136:1899-907.
17. Miescher S, Stoeck M, Barras QC, Barrelet L, von Fliedner V. Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes, impaired response to mitogen-driven stimulation despite T-cell receptor expression. Int J Cancer 1988;42:659-66.
18. Ghosh AK, Moore M. Tumour-infiltrating lymphocytes in cervical carcinoma. Eur J Cancer 1992;28A:1910-6.
19. Hilders CGJM, Ras L, van Eendenburg JDH, Nooyen Y, Fleuren GJ. Isolation and characterization of tumor-infiltrating lymphocytes from cervical carcinoma. Int J Cancer 1994;57:805-13.
20. Sheu BC, Lin RH, Ho HH, Huang SC. Down-regulation of CD25 expression on activated tumor-infiltrating lymphocytes derived from human cervical carcinoma. Hum Immunol 1997;56:39-47.
21. Chen L, Linsley PS, Hellström KE. Costimulation of T cells for tumor immunity. Immunol Today 1993;14:483-6.
22. Cheng TY, Wu JT, Lin RH. Induction of tumor-specific T cell response by cognating tumor cells with foreign antigen-primed Th cells. Int Immunol 1998;10:1397-406.
23. Kern DE, Klarnet JP, Jensen MCV, Greenberg PD. Requirement for recognition of class II and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL. J Immunol 1986;136:4303-10.
24. Greenberg PD. Adoptive T cells therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv Immunol 1991;49:281-355.
25. + tumor cells are potent vaccines for stimulating tumor rejection on tumor-bearing mice. J Exp Med 1995;181:619-29.
26. Hernberg M, Turunen JP, Muhonen T, Pyrhonen S. Tumor-infiltrating lymphocytes in patients with metastatic melanoma receiving chemoimmunotherapy. J Immunother 1997; 20:488-95.
27. - cells in tumor-infiltrating lymphocytes of renal cell carcinoma associated with tumor progression. Eur Urol 1992;22:323-8.
28. Yoshino I, Yano T, Murata M, Miyamoto M, Ishida T, Sugimachi K, et al. Phenotypes of lymphocytes infiltrating non-small cell lung cancer tissues and its variation with histolgical types of cancer. Lung Cancer 1993;10:13-9.